BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqembi (lecanemab) has been approved for once every four weeks intravenous (IV) maintenance dosing for the ...
Lucara Diamond Corp. today reports its results for the quarter ended 30, 2025. All amounts are . PDF version Q3 2025 HIGHLIGHTS A total of 101,422 carats were sold, generating $51.2 million in revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback